Inactive Instrument

Press Releases Savara Inc Nyse

Equities

US5763141083

End-of-day quote Nyse Other stock markets
- ^USD	-

01:39pm	Savara's Phase 3 Trial for Molgramostim Nebulizer Solution Meets Primary Endpoint; Shares Rise Pre-Bell	MT
12:39pm	Savara's rare lung disease drug meets main goal in late-stage study	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	11:31am	BU
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	01:06am	BU
Savara to Present at the Jefferies Global Healthcare Conference	05-29	BU
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis at the American Thoracic Society International Conference 2024	05-20	AQ
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024	05-19	BU
Savara Announces New Employment Inducement Grant	05-16	BU
Savara Reports First Quarter 2024 Financial Results and Provides Business Update	05-09	BU
Savara to Present at the Citizens JMP Life Sciences Conference	05-07	BU
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024	04-08	BU
Savara Announces New Employment Inducement Grant	03-25	AQ
Savara Announces New Employment Inducement Grant	03-22	BU
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update	03-07	BU
Savara to Present at the Barclays 26th Annual Global Healthcare Conference	03-06	BU
Savara Announces New Employment Inducement Grant	02-02	BU
Savara to Present at Two Upcoming Healthcare Conferences	01-31	BU
Savara Introduces aPAP ClearPath, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis	12-22	AQ
Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	12-21	BU
Savara Added to the NASDAQ Biotechnology Index	12-20	BU
Savara Announces New Employment Inducement Grant	12-18	AQ
Savara Announces New Employment Inducement Grant	12-15	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Savara Inc Nyse

Equities

US5763141083

Press Releases

Filters